Anupam Rama

Stock Analyst at JP Morgan

(3.69)
# 795
Out of 5,038 analysts
279
Total ratings
47.56%
Success rate
8.02%
Average return

Stocks Rated by Anupam Rama

IDEAYA Biosciences
Oct 23, 2025
Maintains: Overweight
Price Target: $74$79
Current: $28.60
Upside: +176.22%
Cogent Biosciences
Oct 21, 2025
Maintains: Overweight
Price Target: $30$44
Current: $14.67
Upside: +199.93%
Replimune Group
Oct 20, 2025
Upgrades: Neutral
Price Target: $11
Current: $8.75
Upside: +25.79%
RAPT Therapeutics
Oct 20, 2025
Upgrades: Overweight
Price Target: $13$55
Current: $29.95
Upside: +83.64%
Cidara Therapeutics
Oct 10, 2025
Initiates: Overweight
Price Target: $200
Current: $97.97
Upside: +104.14%
Maze Therapeutics
Sep 29, 2025
Maintains: Overweight
Price Target: $27$37
Current: $30.12
Upside: +22.86%
Camp4 Therapeutics
Sep 16, 2025
Downgrades: Neutral
Price Target: n/a
Current: $3.40
Upside: -
BridgeBio Pharma
Sep 3, 2025
Maintains: Overweight
Price Target: $55$70
Current: $53.37
Upside: +31.16%
Solid Biosciences
Aug 14, 2025
Maintains: Overweight
Price Target: $15$13
Current: $5.55
Upside: +134.23%
ORIC Pharmaceuticals
Aug 14, 2025
Maintains: Overweight
Price Target: $20$17
Current: $12.06
Upside: +40.96%
Maintains: Overweight
Price Target: $28$29
Current: $7.94
Upside: +265.24%
Upgrades: Neutral
Price Target: $15
Current: $18.21
Upside: -17.63%
Maintains: Overweight
Price Target: $56$53
Current: $29.77
Upside: +78.03%
Maintains: Overweight
Price Target: $35$37
Current: $28.70
Upside: +28.92%
Maintains: Neutral
Price Target: $140$145
Current: $142.90
Upside: +1.47%
Upgrades: Neutral
Price Target: $24
Current: $21.68
Upside: +10.70%
Maintains: Overweight
Price Target: $42$80
Current: $33.64
Upside: +137.81%
Maintains: Overweight
Price Target: $104$117
Current: $33.83
Upside: +245.85%
Maintains: Overweight
Price Target: $39$41
Current: $15.10
Upside: +171.52%
Maintains: Overweight
Price Target: $44$51
Current: $28.05
Upside: +81.82%
Maintains: Overweight
Price Target: $39$34
Current: $7.19
Upside: +372.88%
Maintains: Overweight
Price Target: $42$44
Current: $27.53
Upside: +59.83%
Maintains: Overweight
Price Target: $16$17
Current: $8.36
Upside: +103.35%
Maintains: Overweight
Price Target: $39$40
Current: $38.41
Upside: +4.14%
Maintains: Overweight
Price Target: $100$125
Current: $90.72
Upside: +37.79%
Initiates: Neutral
Price Target: n/a
Current: $3.08
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $0.58
Upside: -
Upgrades: Neutral
Price Target: n/a
Current: $3.34
Upside: -
Maintains: Overweight
Price Target: $11$13
Current: $2.95
Upside: +340.68%
Maintains: Neutral
Price Target: $80$90
Current: $6.21
Upside: +1,350.44%
Downgrades: Neutral
Price Target: $250
Current: $14.63
Upside: +1,608.82%
Downgrades: Neutral
Price Target: n/a
Current: $7.94
Upside: -
Initiates: Overweight
Price Target: $58
Current: $55.43
Upside: +4.64%
Upgrades: Neutral
Price Target: $7$12
Current: $14.14
Upside: -15.13%
Upgrades: Neutral
Price Target: $29$37
Current: $6.14
Upside: +502.61%
Upgrades: Overweight
Price Target: $55
Current: $73.33
Upside: -25.00%
Initiates: Overweight
Price Target: $28
Current: $2.24
Upside: +1,150.00%
Downgrades: Neutral
Price Target: $54
Current: $41.93
Upside: +28.79%
Initiates: Overweight
Price Target: $45
Current: $0.72
Upside: +6,150.00%
Initiates: Overweight
Price Target: $27
Current: $16.46
Upside: +64.03%
Downgrades: Neutral
Price Target: $133$137
Current: $460.09
Upside: -70.22%
Downgrades: Neutral
Price Target: $29$48
Current: $8.88
Upside: +440.54%
Upgrades: Overweight
Price Target: n/a
Current: $10.05
Upside: -
Maintains: Overweight
Price Target: $225$270
Current: $3.79
Upside: +7,024.01%
Initiates: Overweight
Price Target: $30
Current: $1.28
Upside: +2,243.75%
Upgrades: Neutral
Price Target: n/a
Current: $66.30
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $1.61
Upside: -